ADHD and depression: investigating a causal explanation.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 7 4 2020
medline: 14 1 2022
entrez: 7 4 2020
Statut: ppublish

Résumé

Attention-deficit hyperactivity disorder (ADHD) is associated with later depression and there is considerable genetic overlap between them. This study investigated if ADHD and ADHD genetic liability are causally related to depression using two different methods. First, a longitudinal population cohort design was used to assess the association between childhood ADHD (age 7 years) and recurrent depression in young-adulthood (age 18-25 years) in N = 8310 individuals in the Avon Longitudinal Study of Parents and Children (ALSPAC). Second, two-sample Mendelian randomization (MR) analyses examined relationships between genetic liability for ADHD and depression utilising published Genome-Wide Association Study (GWAS) data. Childhood ADHD was associated with an increased risk of recurrent depression in young-adulthood (OR 1.35, 95% CI 1.05-1.73). MR analyses suggested a causal effect of ADHD genetic liability on major depression (OR 1.21, 95% CI 1.12-1.31). MR findings using a broader definition of depression differed, showing a weak influence on depression (OR 1.07, 95% CI 1.02-1.13). Our findings suggest that ADHD increases the risk of depression later in life and are consistent with a causal effect of ADHD genetic liability on subsequent major depression. However, findings were different for more broadly defined depression.

Sections du résumé

BACKGROUND
Attention-deficit hyperactivity disorder (ADHD) is associated with later depression and there is considerable genetic overlap between them. This study investigated if ADHD and ADHD genetic liability are causally related to depression using two different methods.
METHODS
First, a longitudinal population cohort design was used to assess the association between childhood ADHD (age 7 years) and recurrent depression in young-adulthood (age 18-25 years) in N = 8310 individuals in the Avon Longitudinal Study of Parents and Children (ALSPAC). Second, two-sample Mendelian randomization (MR) analyses examined relationships between genetic liability for ADHD and depression utilising published Genome-Wide Association Study (GWAS) data.
RESULTS
Childhood ADHD was associated with an increased risk of recurrent depression in young-adulthood (OR 1.35, 95% CI 1.05-1.73). MR analyses suggested a causal effect of ADHD genetic liability on major depression (OR 1.21, 95% CI 1.12-1.31). MR findings using a broader definition of depression differed, showing a weak influence on depression (OR 1.07, 95% CI 1.02-1.13).
CONCLUSIONS
Our findings suggest that ADHD increases the risk of depression later in life and are consistent with a causal effect of ADHD genetic liability on subsequent major depression. However, findings were different for more broadly defined depression.

Identifiants

pubmed: 32249726
doi: 10.1017/S0033291720000665
pii: S0033291720000665
pmc: PMC8381237
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1890-1897

Subventions

Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204895/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M006727/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102215/2/13/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Références

Eur Child Adolesc Psychiatry. 2019 Oct;28(10):1375-1384
pubmed: 30834985
J Affect Disord. 2018 Feb;227:56-64
pubmed: 29053976
J Pediatr Psychol. 2007 Jul;32(6):643-54
pubmed: 17569716
Psychol Med. 2019 May;49(7):1079-1088
pubmed: 30606278
Biol Psychiatry. 2016 Dec 15;80(12):916-922
pubmed: 27086545
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Int J Epidemiol. 2016 Dec 1;45(6):1961-1974
pubmed: 27616674
PLoS Genet. 2017 Nov 17;13(11):e1007081
pubmed: 29149188
Psychol Assess. 2014 Sep;26(3):752-62
pubmed: 24749755
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Int J Methods Psychiatr Res. 2018 Sep;27(3):e1610
pubmed: 29465165
Annu Rev Psychol. 2016;67:567-85
pubmed: 26442667
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Psychiatry Res. 1998 Nov 16;81(2):259-68
pubmed: 9858042
BMC Psychiatry. 2016 Aug 26;16:301
pubmed: 27561259
J Child Psychol Psychiatry. 2009 Dec;50(12):1468-76
pubmed: 19508494
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
Psychol Bull. 2018 Dec;144(12):1229-1246
pubmed: 30475016
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
Br J Psychiatry. 2018 Sep;213(3):526-534
pubmed: 29957167
Nat Genet. 2018 Dec;50(12):1728-1734
pubmed: 30374074
Mol Psychiatry. 2019 Apr;24(4):562-575
pubmed: 29892054
Psychol Med. 2019 Dec;49(16):2745-2753
pubmed: 30563581
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
JAMA Psychiatry. 2019 Jul 1;76(7):730-738
pubmed: 30942833
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Int J Epidemiol. 2018 Aug 1;47(4):1264-1278
pubmed: 29961852
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
Am J Psychiatry. 2004 Apr;161(4):646-53
pubmed: 15056510
Pediatrics. 2016 Dec;138(6):
pubmed: 27940701
Atten Defic Hyperact Disord. 2015 Mar;7(1):27-38
pubmed: 24942707
Nature. 2015 Jul 30;523(7562):588-91
pubmed: 26176920
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):276-95
pubmed: 16492260
J Child Psychol Psychiatry. 2013 Oct;54(10):1038-46
pubmed: 24007415
J Child Psychol Psychiatry. 2003 Oct;44(7):988-96
pubmed: 14531581

Auteurs

Lucy Riglin (L)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Beate Leppert (B)

Population Health Sciences, Bristol Medical School and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Christina Dardani (C)

Population Health Sciences, Bristol Medical School and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Centre of Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK.

Ajay K Thapar (AK)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Frances Rice (F)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Michael C O'Donovan (MC)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

George Davey Smith (G)

Population Health Sciences, Bristol Medical School and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Evie Stergiakouli (E)

Population Health Sciences, Bristol Medical School and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Oral and Dental Sciences, University of Bristol, Bristol, UK.

Kate Tilling (K)

Population Health Sciences, Bristol Medical School and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Anita Thapar (A)

Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH